Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Effects of CD24 "Don't Eat Me" Signal Blockade in Combination with Anti-CD47 and Rituximab in Mantle-Cell Lymphoma

Andrea Aroldi, Mario Mauri, Matteo Villa, Federica Malighetti, Federica Cocito, Claudia Voena, Roberto Chiarle, Luca Mologni, Rocco Piazza, Carlo Gambacorti-Passerini

Blood (2022) 140 (Supplement 1): 3136–3138.

https://doi.org/10.1182/blood-2022-159247

Published: 2022

Journal Articles

Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK + anaplastic large cell lymphoma

Blood (2022) 139 (5): 717–731.

https://doi.org/10.1182/blood.2020008136

Published: 2022

Includes: Supplemental data

Journal Articles

Identifying Novel Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Anaplastic Large Cell Lymphoma

Elif Atabay, PhD, Qi Wang, PhD, Ambrogio Chiara, PhD, Taek-Chin Cheong, PhD, Silvia Peola, Geeta G Sharma, PhD, Luca Mologni, PhD, Carlo Gambacorti-Passerini, MD, Claudia Voena, PhD, Roberto Chiarle, MD

Blood (2019) 134 (Supplement_1): 5060.

https://doi.org/10.1182/blood-2019-132188

Published: 2019

Journal Articles

Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice

Ramesh Choudhari, Valerio Giacomo Minero, Matteo Menotti, Roberta Pulito, Cord Brakebusch, Mara Compagno, Claudia Voena, Chiara Ambrogio, Roberto Chiarle

Blood (2016) 127 (10): 1297–1306.

https://doi.org/10.1182/blood-2015-11-683052

Published: 2016

Includes: Supplemental data

Journal Articles

PI3Kdelta Inhibitors Increase Genomic Instability By Upregulating Aid Expression

Mara Compagno, Wang Qi, Chiara Pighi, Feilong Meng, Taek-Chin Cheong, Teresa Poggio, Fernanda Langellotto, Claudia Voena, Monica Gostissa, Frederick Alt, Roberto Chiarle

Blood (2015) 126 (23): 164.

https://doi.org/10.1182/blood.V126.23.164.164

Published: 2015

Journal Articles

The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL

Francesco E. Boccalatte, Claudia Voena, Chiara Riganti, Amalia Bosia, Lucia D'Amico, Ludovica Riera, Mangeng Cheng, Bruce Ruggeri, Ole N. Jensen, Valerie L. Goss, Kimberly Lee, Julie Nardone, John Rush, Roberto D. Polakiewicz, Michael J. Comb, Roberto Chiarle, Giorgio Inghirami

Blood (2009) 113 (12): 2776–2790.

https://doi.org/10.1182/blood-2008-06-161018

Published: 2009

Includes: Supplemental data

Journal Articles

p130Cas mediates the transforming properties of the anaplastic lymphoma kinase

Chiara Ambrogio, Claudia Voena, Andrea D. Manazza, Roberto Piva, Ludovica Riera, Laura Barberis, Carlotta Costa, Guido Tarone, Paola Defilippi, Emilio Hirsch, Elisabetta Boeri Erba, Shabaz Mohammed, Ole N. Jensen, Giorgio Palestro, Giorgio Inghirami, Roberto Chiarle

Blood (2005) 106 (12): 3907–3916.

https://doi.org/10.1182/blood-2005-03-1204

Published: 2005

Journal Articles

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma

Paolo Corradini, Michele Cavo, Henk Lokhorst, Giovanni Martinelli, Carolina Terragna, Ignazio Majolino, Pinuccia Valagussa, Mario Boccadoro, Diana Samson, Andrea Bacigalupo, Nigel Russell, Vittorio Montefusco, Claudia Voena, Gosta Gahrton, the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Blood (2003) 102 (5): 1927–1929.

https://doi.org/10.1182/blood-2003-01-0189

Published: 2003

Journal Articles

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer

Marco Bregni, Anna Dodero, Jacopo Peccatori, Alessandra Pescarollo, Massimo Bernardi, Isabella Sassi, Claudia Voena, Alberto Zaniboni, Claudio Bordignon, Paolo Corradini

Blood (2002) 99 (11): 4234–4236.

https://doi.org/10.1182/blood.V99.11.4234

Published: 2002

Journal Articles

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

Paolo Corradini, Corrado Tarella, Attilio Olivieri, Alessandro M. Gianni, Claudia Voena, Francesco Zallio, Marco Ladetto, Michele Falda, Moira Lucesole, Anna Dodero, Fabio Ciceri, Fabio Benedetti, Alessandro Rambaldi, Maria R. Sajeva, Moreno Tresoldi, Alessandro Pileri, Claudio Bordignon, Marco Bregni

Blood (2002) 99 (1): 75–82.

https://doi.org/10.1182/blood.V99.1.75

Published: 2002

Journal Articles

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

Massimo Massaia, Paolo Borrione, Silvano Battaglio, Sara Mariani, Eloise Beggiato, Patrizia Napoli, Claudia Voena, Alberto Bianchi, Marta Coscia, Barbara Besostri, Silvia Peola, Thomas Stiefel, Jos Even, Domenico Novero, Mario Boccadoro, Alessandro Pileri

Blood (1999) 94 (2): 673–683.

https://doi.org/10.1182/blood.V94.2.673

Published: 1999

Journal Articles

Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

Paolo Corradini, Monica Astolfi, Cristina Cherasco, Marco Ladetto, Claudia Voena, Daniele Caracciolo, Alessandro Pileri, Corrado Tarella

Blood (1997) 89 (2): 724.

https://doi.org/10.1182/blood.V89.2.724

Published: 1997

NARROW

Effects of CD24 "Don't Eat Me" Signal Blockade in Combination with Anti-CD47 and Rituximab in Mantle-Cell Lymphoma

Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK + anaplastic large cell lymphoma

Identifying Novel Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Anaplastic Large Cell Lymphoma

Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice

PI3Kdelta Inhibitors Increase Genomic Instability By Upregulating Aid Expression

The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL

p130Cas mediates the transforming properties of the anaplastic lymphoma kinase

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only